Stocks
Equities analysis, sector rotation, and individual stock coverage
Chipotle Pulls Jalapenos from Some Locations after Salmonella Investigation
The burrito chain removed the ingredient from select stores as health officials investigate a potential salmonella outbreak.
StocksOpen USD Rattles Circle Stock but Key Backers Still Support USDC
Circle shares slide as launch of rival stablecoin Open USD sparks competitive fears, while institutional backers reaffirm support for USDC.
StocksChipotle Stock Falls on Potential Link to Salmonella Outbreak in Minnesota
Shares of Chipotle Mexican Grill slipped Monday after reports linked the chain to a salmonella outbreak in Minnesota, reawakening food-safety concerns that have historically hit fast-casual stocks.
StocksJPMorgan Strategists See Tech Taking a Back Seat for Rest of 2026
The call suggests megacap growth may cede leadership as earnings broaden and valuations face scrutiny.
StocksBitget Set to Exit Japan, Close All Remaining Positions by Year-End
Bitget will wind down its Japanese arm and close all outstanding positions before year-end 2026, adding to a wave of exchange exits from one of Asia's most stringent crypto regulatory environments.
StocksAstraZeneca Slides, Bristol Myers Jumps on Reported Merger Talks; Analysts Call Deal ‘Odd’
Shares moved in opposite directions Monday after reports of tie-up discussions between two oncology heavyweights, but analysts question the strategic logic.
StocksTim Cook's Lasting Legacy: Keeping Apple's Eye on the Ball
An assessment of Tim Cook's tenure as CEO highlights his defining focus — keeping Apple disciplined amid more than a decade of growth, with market cap now near $3 trillion.
StocksFinancial Stocks Crush It as Charts Signal Breakout Rally May Continue
Technical chart analysis suggests the financial sector's breakout rally may have just begun, with key levels pointing to further upside.
StocksNVO Stock Drops 4% After Novo Nordisk Trial Failure, Adding to Woes
The Danish pharmaceutical giant faces mounting pressure as a clinical trial failure compounds existing concerns about its weight-loss drug franchise.
StocksClear Street Offers Pre-IPO Access to $188 Billion AI Giant Databricks
Fintech broker expands its pre-IPO trading platform to include one of the most anticipated private market listings in the AI sector.
StocksConsumer IPOs Hit Multi-Year Lows as Companies Opt to Stay Private
A growing number of consumer-facing businesses are choosing to remain private rather than pursue traditional public offerings, reshaping how these companies access capital.
StocksAI Stocks May Have Bottomed Out; Investors Eye Next Moves
Market participants weigh whether recent selling pressure in artificial intelligence equities has run its course, with attention turning to upcoming catalysts that could confirm or deny a sustainable reversal.